x
ServiziMenu principaleHome
Home > Sponsors & Exhibition > Sponsored satellite symposia
Share on Share on Facebook Twitter Share on Linkedin Print this page

Sponsored satellite symposia

Gilead

06 November 2025 – 09:00-10:30

No Time to Wait – A New Model of Care in Metastatic Breast Cancer Panel

 

 

 

Clinical insights

Carlo Palmieri, UK

 

Unique challenges of younger women diagnosed with MBC

Jennifer Merschdorf, US

 

How advocacy fills gaps in care

MJ DeCoteau, CA

 

Bringing lived experience and insight

Terlisa Shepard, US

 

 

 

 

 

Chairs
Carlo Palmieri, Professor of Translational Oncology & Medical Oncologist University of Liverpool, UK
Jennifer Merschdorf, Young Survival Coalition, US

 

Panellists
MJ DeCoteau, Rethink Breast Cancer, CA
Terlisa Shepard, metastatic breast cancer patient and advocate, US

   

PeerView

06 November 2025 – 11:00-12:30

Charting New Paths in the Treatment of ER+, HER2- MBC
Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases

 

 

11:00-11:15

Check-In & Lunch

 

11:15-12:30

Symposium

 

 

Welcome and Goal-Setting

 

 

Refining the First-Line Treatment of ER+, HER2- MBC to Maximize the Benefits and Minimize the Risks to Patients

 

 

Overcoming the Limitations of Standard Endocrine Therapies in ER+, HER2- MBC With Oral SERDs, Combinations, and Other  Novel Approaches

 

 

Exploring Patient Journeys in ER+, HER2- MBC: Case-Based Illustrations of Integration of Modern Treatment Approaches

 
 

Seeking Consensus in Clinical Complexity: Recap, New Treatment Algorithm, and Key Recommendations

 
 

Faculty-Audience Q&A

 

 

12:30 WET: Adjourn

 

 

 

 

 

 

Chair
Stephen Johnston, The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research, Chelsea, London, United Kingdom

 

Presenter
Valentina Guarneri, University of Padova, Istituto Oncologico Veneto IRCCS Padova, Italy

 

Presenter
Professor Patrick Neven, Multidisciplinary Breast Centre University Hospitals, Leuven, Belgium

 

This activity is supported by an educational grant from Lilly and is provided by PVI, PeerView Institute for Medical Education.

 

  

Daiichi Sankyo | AstraZeneca

07 November 2025 – 13:00-14:00

The ADCs Puzzle: Optimizing patient outcome in ABC

 

 

13:00-13:05

Building the frame with treatment goals in ABC

Valentina Guarneri, IT

13:05-13:15

ADCs in HER2-positive ABC — the first piece falls into place

Carmine De Angelis, IT

13:15-13:30

ADCs in HR-positive/HER2- negative ABC and in TNBC — what we need to close the gaps

Valentina Guarneri, IT

13:30-13:40

Looking for missing pieces — challenges and opportunities of implementing ADCs in routine clinical practice

Peter Faschin, DE

13:40-13:55

Panel discussion

All speakers

13:55-14:00

Future directions for completing the puzzle

Valentina Guarneri, IT

 

 

 

 

 

Satellite Symposia Faculty
Valentina Guarneri, University of Padova, Istituto Oncologico Veneto IRCCS, Padova, IT
Carmine De Angelis, Scuola Superiore Meridionale, Naples, Italy NCI G. Pascale, Naples, IT
Peter Faschin, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, DE

VAT/NIPC 515 732 230